Perrigo said Thursday that it would cut about 6% of its workforce, sell its vitamins business and repurchase up to $2 billion in shares as the generic drug company continues to fend off a takeover by Mylan.
from WSJ.com: US Business http://ift.tt/1RqrSGn
via IFTTT
No comments:
Post a Comment